Dr. Aaron D. Goldberg

Dr. Aaron D. Goldberg, MD, PhD, is a board-certified hematologist and medical oncologist specializing in the care of patients with leukemia and myelodysplastic syndrome at Memorial Sloan Kettering Cancer Center. He holds board certifications in hematology, medical oncology, and internal medicine, and works as part of a multidisciplinary team of physicians and nurses dedicated to delivering comprehensive, advanced care for patients and their families. Trained as both a clinician and a scientist, Dr. Goldberg brings a dual perspective to patient care, combining attentive, personalized medicine with a rigorous molecular approach to understanding each patient's disease and determining the most effective treatment strategy.

Dr. Goldberg leads multiple clinical trials at MSK evaluating novel therapies for leukemia, including immunotherapy, epigenetic therapy, and small-molecule targeted approaches. His laboratory-based research, conducted in collaboration with scientific colleagues, focuses on the molecular features of acute myeloid leukemia with the long-term goal of developing treatments that are more effective and less toxic than traditional chemotherapy. By integrating clinical trial leadership with translational laboratory investigation, he works to expand the range of therapeutic options available to patients and to move the field beyond conventional treatment approaches.

Known for his compassionate and thorough approach to patient care, Dr. Goldberg takes time to listen carefully to his patients' concerns and to provide clear, complete answers about their diagnoses and treatment options. He treats every patient with the same dedication he would give a member of his own family, reflecting a deep personal commitment to their well-being. His work is guided by the conviction that every patient deserves tireless advocacy, individualized attention, and access to the most advanced therapies available.